Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-21-112499

Director sold 4,000 shares at $9.40 ($37,591)

  • Director acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2021-08-31 Option exercise +4,000 $4.13 $16,500 129,046 D
Kraus Al Director 2021-08-31 Sale −4,000 $9.40 $37,591 125,046 D
Derivatives
Kraus Al Director 2021-08-31 Option exercise · Stock Option (right to buy) −4,000 0 D
Open-market sales · 4,000 sh · avg $9.40 · $37,591
Loading xslF345X03/tm2126875-1_4seq1.xml…